Endometrial Ablation Market to Reach USD 6.6 Billion by 2033 at a 7.3% of CAGR, Driven by Growing Awareness of Women’s Health and Minimally Invasive Procedures

Endometrial Ablation Market
Endometrial Ablation Market

The global Endometrial Ablation Market is poised for significant growth over the next decade, according to a new report from Future Market Insights. Valued at US$ 3.2 billion in 2022, the market is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2033, reaching a valuation of approximately US$ 6.6 billion by the end of the forecast period. The market is projected to offer an absolute dollar opportunity of nearly US$ 3.4 billion during this time.

Endometrial ablation, a minimally invasive procedure to treat abnormal uterine bleeding (menorrhagia), is increasingly gaining traction due to rising awareness about women’s health, the growing preference for less invasive surgeries, and the increasing prevalence of conditions like heavy menstrual bleeding.

Key Market Drivers:

  • Rising Awareness of Women’s Health: Growing efforts to raise awareness about menstrual health and the availability of advanced treatments for conditions such as menorrhagia are key factors driving the adoption of endometrial ablation procedures.
  • Demand for Minimally Invasive Procedures: Endometrial ablation is favored for its minimally invasive nature, leading to faster recovery times, fewer complications, and improved patient outcomes. This trend is expected to continue propelling market growth.
  • Increasing Prevalence of Menorrhagia: The rising incidence of menorrhagia, a condition characterized by heavy menstrual bleeding, is contributing to the growing demand for effective treatments like endometrial ablation.

Regional Insights: North America is anticipated to lead the global endometrial ablation market, driven by advanced healthcare infrastructure, a high level of awareness regarding women’s health issues, and the presence of key market players. Europe is expected to follow closely, while the Asia-Pacific region is projected to witness robust growth due to improving healthcare access, increasing medical awareness, and the rising demand for minimally invasive treatments in countries such as India and China.

Market Outlook: As awareness surrounding women’s health continues to grow and healthcare providers adopt minimally invasive procedures, the endometrial ablation market is set to experience significant growth in the coming years. With ongoing research and technological advancements in this field, the market is well-positioned for sustained expansion through 2033.

Revenue of Endometrial Ablation Market from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033

As per the Endometrial Ablation Market industry research by Future Market Insights – a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around a CAGR of 5.9%. Growing with an absolute dollar opportunity of US$ 3.4 Billion from 2023 to 2033, the market is projected to reach US$ 6.8 Billion by 2033.

Competitive Analysis

The key players in the global endometrial ablation market are Medtronic, CooperSurgical Inc., Boston Scientific Corp., Ethicon, Inc., Olympus Corp., Richard Wolf GmbH, AngioDynamics, Hologic, Inc., and Minerva Surgical, Inc.

A few of the recent developments in the market are:

  • In February 2021, CooperSurgical, a division of CooperCompanies, has acquired Aegea Medical, nearly a year after the company received FDA approval for its Mara water vapor ablation system for severe menstrual bleeding.
  • In May 2019, Medtronic Plc announced a partnership with Koninklijke Philips N.V. This collaboration is projected to result in an integrated cryoablation solution that is cutting-edge in terms of image guidance.
  • In April 2021, Olympus Corporation relocated its Therapeutic Solutions Division’s worldwide headquarters from Tokyo to the United States in order to gain better access to the medical industry and earn more revenue through expanded commercial prospects.
  • In June 2021, Boston Scientific purchased the remaining shares of FARAPULSE. Boston Scientific’s electrophysiology sector was bolstered by the acquisition, which added pulsed-field ablation technology to the company’s offerings.

A Full Report Overview

Market Segments Covered in Endometrial Ablation Market Analysis

By Type:

  • Devices
    • Cryoablation
    • Radiofrequency Ablation
    • Hydrothermal Ablation
    • Thermal Balloon
    • Microwave Energy
  • Procedures

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *